Aging Clinical and Experimental Research

, Volume 4, Issue 3, pp 257–259

Growth hormone, IGF-I, gonadal steroids, and aging

  • S. Mitchell Harman
  • M. R. Blackman
Symposiums Report Conference on the physiologic basis of frailty April 28, 1992, Baltimore, Maryland, U.S.A.


Aging gonadal steroids growth hormone IGF-I 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Harris T.B., Feldman J.J.: Implications of health statusin analysis of risk in older persons. J. Aging Health 3:262–284, 1991.PubMedCrossRefGoogle Scholar
  2. 2.
    Kelijman M.: Age-related alterations of the growthhormone/insulin-like-growth-factor I axis. JAGS 39:295–307, 1991.Google Scholar
  3. 3.
    Ho K.Y., Evans W.S., Blizzard R.M., Veldhuis J., Merriam G., Samojlik E., Furlanetto R., Rogol A., Kaiser D., Thorner M.O.: Effects of sex and age on 24-hourprofile of growth hormone secretion in men and women:Importance of endogenous estradiol concentrations.J. Clin. Endocrinol. Metab. 64: 51–58, 1987.CrossRefGoogle Scholar
  4. 4.
    Pavlov E.P., Harman S.M., Merriam G.R., Gelato M.C., Blackman M.R.: Responses of growth hormoneand somatomedin-C to GH-releasing hormone inhealthy aging men. J. Clin. Endocrinol. Metab. 62:595–600, 1986.PubMedCrossRefGoogle Scholar
  5. 5.
    Iranmanesh A., Lizarralde G, Veldhuis J.D.: Age andrelative adiposity are specific negative determinantsof the frequency and amplitude of growth hormone(GH) secretory bursts and the half-life of endogenousGH in healthy men. J. Clin. Endocrinol. Metab. 73:1081–1088, 1991.PubMedCrossRefGoogle Scholar
  6. 6.
    Marcus R., Butterfield G., Holloway L., Gilliland L., Baylink D.J., Hintz R.L., Sherman B.M.: Effects ofshort-term administration of recombinant human growthhormone to elderly people. J. Clin. Endocrinol.Metab. 70: 519–527, 1990.PubMedCrossRefGoogle Scholar
  7. 7.
    Kaiser F.E., Silver A.J., Morley J.E.: The effect of recombinanthuman growth hormone on malnourishedolder individuals. J. Am. Geriatr. Soc. 39: 235–240,1991.PubMedGoogle Scholar
  8. 8.
    Rudman D., Feller A.G., Nagraj H.S., Gergans G.A., Lalitha P., Goldperg A.F., Schlenker R.A., Cohn L., Rudman I.W., Mattson D.E.: Effect of human growthhormone in men over 60 years old. N. Engl. J. Med. 323: 1–6, 1990.PubMedCrossRefGoogle Scholar
  9. 9.
    Iovino M., Monteleone P., Steardo L.: Repetitivegrowth hormone-releasing hormone administration restoresthe attenuated growth hormone (GH) responseto GH releasing hormone testing in normal aging. J.Clin. Endocrinol. Metab. 69: 910–913, 1989.PubMedCrossRefGoogle Scholar
  10. 10.
    Corpas E., Harman S.M., Piñeyro M.A., Roberson R., Blackman M.R.: GHRH 1-29 twice daily reversesthe decreased GH and IGF-I levels in old men. J. Clin.Endocrinol. Metab. 1992 (in press).Google Scholar
  11. 11.
    Griggs R.C., Kingston W., Jozefowicz R.F., Herr B.E.:Effect of testosterone on muscle mass and muscle proteinsynthesis. J. Appl. Physiol. 66: 498–503, 1989.PubMedGoogle Scholar

Copyright information

© Editrice Kurtis s.r.l. 1992

Authors and Affiliations

  • S. Mitchell Harman
    • 1
  • M. R. Blackman
    • 1
  1. 1.Departments of Medicine Francis Scott Key Medical Center and Johns Hopkins University School of MedicineGerontology Research Center, N.I.H. — NIA, andBaltimoreUSA

Personalised recommendations